Seneschal Advisors’s MetLife MET Stock Holding History

Seneschal Advisors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02K	Hold	12	–	–	﹤0.01%	254
2026 Q1	$849	Buy	12 +2	+20%	+$150	﹤0.01%	262
2025 Q4	$790	Hold	10	–	–	﹤0.01%	268
2025 Q3	$824	Buy	+10	New	+$787	﹤0.01%	259

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Seneschal Advisors's MET Position: Q2 2026 in Review

Seneschal Advisors held its MetLife (MET) position steady in Q2 2026 at 12 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #254.

Seneschal Advisors first reported a position in MET in Q3 2025 and has held it in 4 quarters since. 1,438 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Seneschal Advisors held 12 shares of MetLife worth $1.02K as of Q2 2026.
Seneschal Advisors left its MetLife share count unchanged in Q2 2026.
MetLife made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #254 holding.
Seneschal Advisors first reported a position in MetLife in Q3 2025 and has held it in 4 quarters since.
1,438 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.